<
Many listed pharmaceutical companies "Lie Gun" environmental protection Order or face price increases
Release time: 2016-11-22 & nbsp & nbsp & nbsp Source: Anonymous
  On the evening of November 21,North China Pharmaceutical Release Refined announcement on the suspension of production,Stop production by relevant units until the end of the year preliminary calculation,Preparation product sales are not affected,It will not affect the company's current income, The raw and drug part will affect the company's current profit of about 50 million yuan。 It is reported,North China Pharmaceuticals and some subordinates (sub -) companies received "Shijiazhuang City's Air Pollution Prevention and Treatment Order" on the 18th,Schedules order all the pharmaceutical companies in the city to discontinue production,No resumption of work without the approval of the municipal government。
 
  November 17,Hebei Provincial Atmospheric Office issued "Atmospheric Pollution Prevention and Control Order 2", Subsequent,The People's Government of Shijiazhuang City issued the "Implementation Plan on Carrying out the Sword Sliming Action",File requirements from November 17, 2016 to December 31, 2016,Implement list formula management for industries such as pharmaceuticals,In principle, all volatile organic matter production processes are discontinued,Special circumstances cannot be discontinued,It must be reported to the municipal government's approval to implement a limited production reduction and emission reduction。
 
  Shi Lichen, the person in charge of Beijing Dingchen Medical Management Consultation Center, pointed out to the 21st Century Business Herald reporter,& ldquo; Volatile organic matter & rdquo;,Shijiazhuang is one of the important raw and drug production bases,Gathering many well My stake betting appStake Sports Betting-known raw materials and drug production enterprises,Rugao Group、North China Pharmaceutical、Shengxue Pharmaceutical, etc.。& ldquo; Now is the end of the year,For pharmaceutical companies, it is a large quantity for medication,If it is discontinued for a long time,The impact on pharmaceutical companies must be great。& rdquo;
 
  Another industry person pointed out,Previously due to environmental quality guarantee,Vitamin production enterprises in Hangzhou and its surrounding areas,Enter the collective discontinuation mode in late August,VA、VE and other varieties appear price increases。and increasingly stricter with the prevention and control of air pollution,Under the pressure of environmental protection,Stop production、Limitation of production is bound to bring rising prices of raw drugs。
 
  Many pharmaceutical companies & ldquo; lying guns & rdquo;
 
  November 17,Hebei Provincial Atmospheric Office issued "Atmospheric Pollution Prevention and Control Order 2",Decided to complete the progress of the annual goals and tasks of completing air pollution prevention、Recent pollution cities implement key scheduling。No. 2 scheduling makes it involved in Shijiazhuang、Baoding、Cangzhou、Hengshui and Dingzhou、Xinji 6 City。
 
  Where,Shijiazhuang also released the "Implementation Plan on Carrying out the Sword Sliming Action",Shijiazhuang Municipal Government decided to use pharmaceuticals、Cement、Casting、Iron and Steel、Coal Electric、Strict control measures。Requirement from November 17, 2016 to December 31, 2016,Implement a list -based management of pharmaceutical companies,In principle, all volatile organic matter production processes are discontinued,Special circumstances cannot be discontinued,It must be reported to the municipal government's approval to implement a limited production reduction and emission reduction。
 
  The above plan is the most stringent atmospheric pollution prevention measures in history & ldquo;。
 
  The above & ldquo; There are volatile organic matter production & rdquo; More directions are ray and drug production enterprises,Shijiazhuang is one of the important raw and drug production bases,Gathering many well My stake betting appStake Sports Betting-known raw materials and drug production enterprises。
 
  An industry insider sorted out some of the pharmaceutical companies in Shijiazhuang, which may be affected,Rugao Group Hebei Zhongrun Pharmaceutical Co., Ltd.、Shijiazhuang Ouyi Pharmaceutical Co., Ltd.、Stone Medicine Group Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd.、North China Pharmaceutical Group Xiantai Pharmaceutical Co., Ltd.、North China Pharmaceutical Group Hualai Co., Ltd.、North China Pharmaceutical Huasheng Co., Ltd.、Hebei Wilkang Pharmaceutical (300267,Stock Bar) Co., Ltd.、North China Pharmaceutical Weica Co., Ltd.、North China Pharmaceutical Huamin Pharmaceutical Co., Ltd.、North China Pharmaceutical Co., Ltd. Pharmaceutical Stake Sports BettingGeneral Factory、Hebei stake betting appShengxue Dacheng Pharmaceutical Co., Ltd.。
 
  For this,November 20th,Announcement of Pharmaceuticals in North China,The company conscientiously implements the relevant requirements of the scheduling order and actively cooperates with the relevant work,At the same time,The company has drafted the relevant implementation plan for the suspension of production restrictions to the relevant departments of the municipal government,Strive for early production。The scope of this discontinued production is the company and Shijiazhuang Uchizi (score) company。
 
  North China Pharmaceutical Representation,At present, the company's main raw medicine、Preparation products all have a certain stock,Sales in the short term are not affected,However, in view of the specific time that cannot be determined by this discontinuation,The specific impact of the above matters on the company's production and performance cannot be predicted。
 
  On the evening of November 21,North China Pharmaceuticals issued supplementary announcements,The company is in accordance with the requirements of the "Implementation Plan for Shijiazhuang's Sword Sliming Action",Arrange deployment related work,Current,The company's main products have a certain scale of stocking,Stop production by relevant units until the end of the year preliminary calculation,Preparation product sales are not affected,It will not affect the company's current income, The raw and drug part will affect the company's current profit of about 50 million yuan。
 
  November 21,Stone Medicine Group also issued an announcement,Start a short period of trading from 9 am on November 21,Announcement on the internal news of the receiving notice of the government's suspension of production; on the evening of November 21,Stone Medicine Group issued an announcement again,It receives the "Shijiazhuang's Emotional Pollution Prevention and Treatment Order" in Shijiazhuang City, Hebei Province,Currently applying to Shijiazhuang Municipal Government is allowing to continue to carry out its normal pharmaceutical production in Shijiazhuang。
 
  Shi Lichen pointed out,The reason why the raw medicine deliberately highlights,It is because of more serious pollution during the production process,The exhaust gas generated by it、Wastewater、Large amount of waste residue,Complex waste ingredients,It is serious for environmental and human health hazards。It is understood,my country is a big country of chemicals and drugs,Especially the production capacity of fermented drug products ranks first in the world,Now 70%to 80%of the world's raw medicines are produced in China。
 
  API or facing price increases
 
  Data display,North China Pharmaceuticals mainly produce medicine products such as antibiotics and vitamins,is currently stake sports betting appmy country's largest antibiotic、My stake betting appOne of the vitamin production bases。
 
  21st Century Business Herald Reporter Consultation and Discovery on the website of North China Pharmaceutical Officer,The products produced by Pharmaceuticals in North China include many injections for the treatment of respiratory tract infections.、Amoxicin decentralized tablets、Demulfonic acid left sulfonate, etc.。
 
 An industry person also revealed,This time not only limited to the raw materials but also the preparation product。This is also partially confirmed in the above -mentioned North China Pharmaceutical Announcement。
 
  For this,A person in charge of North China Pharmaceutical pointed out to the 21st Century Business Herald.,Now in communication,Everything is based on the announcement。
 
  Many people in the industry said,For pharmaceutical companies, we should not cut it in one sword。Another,Shi Lichen also pointed out,Now is the end of the year,For pharmaceutical companies, it is a large quantity for medication,If it is discontinued for a long time,The impact on pharmaceutical companies must be great。
 
  2015,In the case of severe haze,In the key supervision of the environmental protection department,Shandong Xinhua Pharmaceutical Co., Ltd. (Lake Garden District) and other chemical enterprises have limited production of more than 30%。Xinhua Pharmaceutical 2015 annual report stated that the sales of chemicals and drugs of the Group by 2.95%compared to the previous year, The main reason for the reduction is the intensification of competition in the chemicals and drug market this year,The sales of some raw materials have decreased。
 
  A medical person pointed out,For enterprises,If the discontinuation is not long,Instant inventory response to sales issues,Reflected in the terminal or just a small -scale price fluctuation。But the haze has no substantial change,Discontinue production of polluting enterprises、production restriction is one of the important pollution control methods,If long -term suspension of production or medication for the terminal market、Price and other aspects have a greater impact。
 
  Due to ensuring environmental quality needs,Vitamin production enterprises in Hangzhou and its surrounding areas,Some have been discontinued in July for production and maintenance,until late August,Enter the collective discontinuation mode, VA、VE and other varieties increase price,Starting from the end of July,The vitamin variety of some enterprises stops the offer。
 
  Shi Lichen pointed out,For pharmaceutical companies,On the one hand, we must face the rise of raw materials,On the other hand, in the background of medical reform,Facing the pressure of price reduction of drugs,and the biggest cost future or environmental protection issues of raw stake betting appand pharmaceutical companies。stake sports betting app& ldquo; Each pharmaceutical company eventually needs to face environmental problems,If the production equipment is upgraded,Treatment of pollution, etc.,This will definitely increase production cost。and under the pressure of environmental protection,Stop production、Limitation of production may also bring about the rise in the prices of raw drugs。& rdquo;